WASHINGTON —The Society for Cardiovascular Angiography & Interventions (SCAI) today announced that Alexandra J. Lansky, MD, MSCAI , has been reappointed to a second five-year term as Editor-in-Chief of JSCAI, the official peer-reviewed journal of SCAI.
SCAI launched JSCAI in 2022 as a fully digital platform to advance interventional cardiology research and practice, appointing Dr. Lansky as its inaugural Editor-in-Chief. Under her leadership, the journal has rapidly expanded its global reach and established itself as a trusted source for original research, clinical guidance, and educational content across the full spectrum of interventional cardiology. In 2025, JSCAI achieved major milestones, including indexing in PubMed Central and surpassing one million article views and downloads, reflecting its growing influence within the interventional cardiology community.
“It has been an honor to build a journal dedicated to advancing clinical science, education, and innovation in interventional cardiology,” said Dr. Lansky, founding Editor-in-Chief of JSCAI and Professor of Medicine and Director of Heart and Vascular Clinical Research at Yale School of Medicine. “The continued growth of JSCAI reflects the strength of our community and the commitment of our authors, reviewers, and editorial board to disseminating knowledge that improves patient care worldwide. The remarkable engagement we are seeing is driven by the quality of the science and the relevance of the content. I am grateful for the opportunity to continue this work and to help guide the journal through its next phase of development.”
JSCAI’s growth has been supported by an innovative editorial model that includes early-career editorial fellows, promoting both rigorous and efficient peer review while cultivating the next generation of academic leaders. Fully digital from its inception, JSCAI has expanded into new multimedia formats, including Conversations in Interventional Cardiology, the launch of the JSCAIBEATS podcast in 2025, and thematic issues focused on emerging areas such as cardiac CTA and artificial intelligence in cardiovascular interventions.
“JSCAI has quickly become an essential platform for knowledge exchange within the interventional cardiology community,” said SCAI President Srihari S. Naidu, MD, MSCAI . “Under Dr. Lansky’s leadership, JSCAI evolved into a trusted forum for high-quality research, practical guidance, and thoughtful discourse that directly informs physicians in their daily practice. Its strength lies in translating complex science into actionable insights for clinicians. As the field continues to advance, JSCAI plays a critical role in bridging innovation, evidence, and practice, and we are proud to see its continued growth and impact under Dr. Lansky’s continued leadership.”